You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 22, Dec 8/22, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Cardiovascular System
 •Statistics and Research Methods
 •Women's Health
 •Women's Health, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Thyrotropin Levels and Coronary Heart Disease Mortality

Reto Auer, MD; Nicolas Rodondi, MD, MAS

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their article, Åsvold et al1 report the findings of the Nord-Trøndelag Health Study (HUNT Study), in which they found a linear and positive association of thyrotropin (TSH) levels within the reference range (0.5-3.5 mIU/L) with coronary heart disease (CHD) mortality in women. In the context of previous studies that did not find an increased risk of CHD with higher TSH levels,2-4 we would like to point out some limitations of the data presented and that these data should be interpreted with caution before clinical use or future revision of guidelines.

Åsvold et al1 report the hazard ratios for 3 analyzed groups of TSH levels (0.5-1.4, 1.5-2.4, and 2.5-3.5 mIU/L) among 5 (<0.5, 0.5-1.4, 1.5-2.4, 2.5-3.5, and ≥3.6 mIU/L) described in the "Statistical Analysis" section. They provide only raw data on CHD mortality for participants with a TSH level of 3.6 mIU/L or . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Bjørn O. Åsvold, Trine Bjøro, Tom Ivar L. Nilsen, David Gunnell, and Lars J. Vatten
Arch Intern Med. 2008;168(8):855-860.
ABSTRACT | FULL TEXT  

RELATED LETTER

Thyrotropin Levels and Coronary Heart Disease Mortality—Reply
Bjørn O. Åsvold, Trine Bjøro, Tom Ivar L. Nilsen, David Gunnell, and Lars J. Vatten
Arch Intern Med. 2008;168(22):2499.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.